The Jikei University School of Medicine urology department

Language

Toward the medical personnel

The 100th Japan urology department society general meeting

List of Department of Urology announcement articles

  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
1 Impact of biochemical failure on long-term clinical outcome after Radical prostatectomy for prostate cancer in Japan. It is 152-157 2004 S Egawa, Y Matsui, K Matsumoto, K Suyama, Y Arai, S Kuwao "<" S Baba Prostate Cancer and Prostatic Disease 7
2 burakiterapi for prostate cancer: Eternal insertion brachytherapy and temporary implant therapy by HDR. Shin Egawa urologic surgery 17(4): 293-299 2004
3 Questionnaire report about usage of antimicrobial agent in the urology department perioperative period. It is 779-786 2004 Shingo Yamamoto, Sojun Kanamaru, Osamu Ogawa, Koichi Kadota, Hiromi Kumon, Kiyohito Ishikawa, Kiyotaka Hoshinaga, Toshihisa Egashira, Seiji Naito, Masatsugu Iwamura, Takefumi Sato, Shiro Baba, Hitoshi Tanaka, Souichi Arakawa, Sadao Kamidono, Masanori Matsukawa, Yasushi Takeyama, Yasushi Tsukamoto, Mitsuru Yasuda, Toru Ishihara, Takashi Deguchi, Hiroshi Kiyota, Shoichi Onodera, Shin Egawa, Yoji Yamada, Tetsuro Muratani, Tetsuro Matsumoto urinary organ 50 required
4 Diagnosis and inspection 3 of special feature) sexually transmitted disease. Condition of a patient and laboratory study 2) gonococcal infection. Hiroshi Kiyota, Shoichi Onodera Medical Technology 32(5): 458-460 2004
5 Benign prostatic hyperplasia. Yasuyuki Suzuki clinical nursing 30(11): 1680-1684 2004
6 Special feature, We urinate and care, Intravesical indwelling catheter which you do for what at such time. Yasuyuki Suzuki clinical nursing 30(11): 1676-1679 2004
7 Special feature: Operation of illustration Ray Ted urolosurgery 18 cystocele. Yasuyuki Suzuki clinic urology department 58 (extra number): 147-158 2004
8 Special feature: 3D image medical advance kidney, urology department domain. Toshio Hasegawa, Nobuki Kato, Yukihiko Oishi, Kunihiko Fukuda Japanese clinical 62(4): 781-789 2004
9 Clinicopathologic examination of quantity of Thymidine Phosphorylase(TdRPase) in renal cell carcinoma and nuclear DNA. Masayuki Tomita, Yukihiko Oishi The Jikei University School of Medicine magazine 119(2): 159-63 2004
10 MRI guide bottom percutaneous cryogenic surgery for renal tumor. Kenta Miki Japanese Jouronal of Endourology "<" ESWL 17(2)
11 Invasive spuamous cell carcinoma of the bladder: Report of 18 cases and review of literature. N Hayashi, K Asano, A Furuta, I Ikemoto, K Kishimoto, H Yamazaki, T Ohnishi, H Takahashi, Y Ohishi Japan urology department society magazine 95(5): 711-717 2004
12 16 clinical analysis that pre-clinical Cushing's syndrome was doubted. Haruhisa Koide, Nozomi Furuta, Hiroki Yamada, Hiroyuki Ito, Koichi Kishimoto, Isao Ikemoto, Yukihiko Oishi. Day urination official journal of a scientific society 95(1): 1-7 2004
13 Two cases of juvenile prostate cancer. Hiroshi Sasaki, Jun Miki, Taro Hasegawa, Toshio Hasegawa, Isao Ikemoto, Yukihiko Oishi urology department bulletin 50(1): 57-59 2004
14 One case of ureter squamous metaplasia. Akio Hoshi, Hideyuki Yamashita, Hiroshi Sasaki, Yasuyuki Kobayashi, island Masanori, Masatoshi Tokunaga, Yukio Usui, Eiji Miyakita, Toshiro Terachi urology department bulletin 50(3): 207-209 2004
15 One case of kidney adenoma detected during lung cancer close inspection. Hiroshi Kagami, Yasuhiro Yamaguchi, Yuichi Hasegawa, Jun Miki, Toshio Hasegawa, Hiroshi Kiyota, Isao Ikemoto, Shin Egawa Japan image medicine bulletin 23(3): 96-101 2004
1 Possibility of new marker of special feature <new development of prostate cancer screening> prostate cancer. Seiichi Saito 1, Shin Egawa, Akihiro Ito 1, Yoichi Arai 1 (1 Tohoku University Faculty of Medicine urology department) Urology View vol.3 No .4 83-90 2005 (young tuna Cal view company):
2 Recovery of quality of life in year after laparoscopic or retropubic radical Prostatectomy: A Multi-institutional longitudinal study. Shunichi Namiki,Shin Egawa, Shiro Baba, Tosiro Terachi, Yukio Usui, Akito Terai, tatsuo Tochigi, Masaaki Kuwahara, Naomasa Ioritani, and Yoichi Arai Urology 65(3) 517-523 2005
3 High-dose rate iridium-192 barchtherapy boost to external beam radiation therapy for prostate cancer in Japanese men. Takefumi Satoh, Masashi Kitano Tetsuo Fujita, Hiromichi Ishiyama, Nibe Yuzuru, Mineko Uemae, Hiroshi Okusa, Ken-ichi Tabata, Kazumasa Matsumoto,Akira Irie, Takashi Arakawa, Shi Egawa, Kazushige Hayakawa, Shiro Baba Japanese Journal of Endourology and ESWL Vol.18 No. 2 273-277 2005
4 Role of endocrine therapy in radical external irradiation for general remarks) local site progressive prostatic carcinoma Shin Egawa clinic urology department 59(5): 267-272 2005
5 RM2 antigen(β1,4GalNAe-desialyl-Lc4) as a new marker for prostate cancer Seiichi Saito, Shin Egawa, Mareyuki Endoh, Seiji Ueno, Akihiro Ito,Kenji Numahata,Makoto Satoh, Aadahito Kuwao, Ahiro Baba, Senitiroh Hakomori and Yoichi Arai International Journal of Cancer 115 :105-113 2005
6 Imaging of imaging Imaging Approach dialysis renal cancer. Shin Egawa, Masayuki Tomita Nephrology Frontier 4(4): 289-2005
7 Role of BPH Impact Index in dysuria evaluation to be seen in benign prostatic hyperplasia patients. Isao Ikemoto, Hiroshi Kiyota, Yasuyuki Suzuki, Yukihiko Oishi, Koichi Kishimoto, Tatsuya Shimomura, Hiroki Yamada, Shinichiro Torii, Takashi Shirai, Hiroyuki Takeuchi, Kazuhiro Abe, Shin Egawa day urination study magazine 96(6): 623-631 2005
8 Special feature urinology infectious disease measures male genital infection: Treatment of prostatitis and the problems. Hiroshi Kiyota Urology View 3(1): 51-57 2004
9 Special feature 2: Perioperative infection prophylaxis of skill in Endourology perioperative infection prophylaxis outside the body shock wave lithodialysis (extracorporeal shock wave lithotripsy;ESWL). Hiroshi Kiyota, Shin Egawa, Shoichi Onodera Japan
Endourology, ESWL official journal of a scientific society 18(2): 220-225 2005
10 Urinary tract infection. Hiroshi Kiyota, Shoichi Onodera Gerontology New Horizon 17 (2): 23(129) -27(133) 2005
11 Urolithiasis and skill in outside the body shock wave lithodialysis. Hiroshi Kiyota space Airlines environment medicine 42(1): 1-10 2005
12 One case that knot was formed at the upper end of ureteral stent. Naoya Kondo, Kyosei Yoshino, Hiroshi Shiono, Yuichi Hasegawa
It is 385-387 2005 urination bulletin 51
13 "Urinary incontinence." Treatment 2005-2007 229-232 2005 of Yasuyuki Suzuki renal disease, dialysis disease
14 Treatment strategy of woman urinary incontinence. It is 475-476 2005 Yasuyuki Suzuki urologic surgery 18
15 Interview of patients with urinary incontinence, process of inspection. Yasuyuki Suzuki nursing technique 51(4): 23-26 2005
16 Interview of patients with urinary incontinence, process of inspection. Yasuyuki Suzuki nursing technique 51(4): 23-26 2005
17 Treatment of benign prostatic hyperplasia merging overactivity bladder. Yasuyuki Suzuki PHYSICIANS TERAPY MANUAL 7(2) 2005
18 Approach of nursing care for pain of urethra laceration with indwelling catheter of elderly man. Yasuyuki Suzuki clinical nursing 31(11): 1712-1714 200
19 OAB measures in BPH. It is 733-736 2005 Yasuyuki Suzuki urologic surgery 18
20 Abnormality and urology department disease of "urinary flow." Nozomi Furuta nursing education 46(12): 1096-1097 2005
21 Of infection prophylaxis measures real; "prevention of insertion, management and urinary tract infection (UTI) of urinary tract catheter. Katsuhisa Endo, Shoichi Onodera clinical medicine 31(8): 1414-1417 2005
22 Usefulness urography -DIP & RP. of step - the old and the new technology of special feature urinary organ imaging Toshio Hasegawa urologic surgery 18(2): 109-115 2005
23 Proteome analysis of prostate cancer. It is 14-21 2005 H Kuruma, S Egawa, M Oh-ishi, Y Kodera & T Maeda Prostate Cancer Prostatic Diseases 8
24 High molecular mass proteome of androgen-independent prostate cancer. It is 1097-1112 2005 Hidetoshi Kuruma, Shin Egawa, Masamichi Oh-Ishi, Yoshio Kodera,Mamoru Satoh, Weigiang Chen, Hiroshi Okusa, Kazumasa Matsumoto,Tadakazu Maeda and Shiro Baba Proteomics 5
25 Adenoviral Infection of Survivin Antisense Sensitizes Prostate Cancer Cells to Etoposide in vivo. Norihiro Hayashi, Koji Asano, Hideaki Suzuki1, Tetsuhisa Yamamoto2,Nobuhiko Tanigawa2, Shin Egawa and Yoshinobu Manome3 (1.Department of Gene Therapy, 2.Department of General and Gastro-Enterological Surgery, Osaka Medical College, 3.Department of Molecular Cell Biology)The Prostate 65:10-19 2005
26 Two cases of non-viral hepatocellular carcinoma which occurred during endocrine therapy of prostate cancer. Yuichi Hasegawa, Masayuki Tomita, Koji Asano, Toshio Hasegawa, Isao Ikemoto, Yukihiko Oishi day urination study magazine 96(4): 503-506 2005
27 Characteristic of prostate cancer discovered by poster session 6 prostate biopsy, foreknowledge factor, other) prostates re-biopsy. Hiroki Yamada, Haruhisa Koide, yuzu*tsune, Tatsuya Shimomura, Kenta Miki, Hiroyuki Takahashi, Shin Egawa urologic surgery 18(8): 1042-1044 2005
28 Imaging of kidney, ureteral neoplasm. Hiroki Yamada, Shin Egawa Nephrology Frontier 4(2): 44-47 2005
29 <reading of and how to use medical examination data> Examination for PSA. Hiroki Yamada, Kenta Miki, Shin Egawa diagnosis and treatment 93(9): 1525-1528 2005
30 Diagnosis and disease classification (staging) of serialization prostate cancer prostate cancer. Tatsuya Shimomura, Shin Egawa
Viding disorders digest dysuria practice 13(1): 67-71 2005
31 Perioperative results of laparoscopic adrenalectomy for primary aldosteronism. Hiroshi Sasaki, Yasuyuki Kobayashi, island Masanori, Yukio Usui, Eiji Miyakita, Toshiyuki Kamoto, Osamu Ogawa, Kazuhiro Okumura, Toshiro Terachi endocrine surgery 22(3): 155-158 2005
32 Pheochromocytoma judging from eye. Hiroshi Sasaki, Toshiro Terachi internal medicine 95(2): 246-349 2005
33 Two cases of metastasis to transitional cell carcinoma small intestine. Akio Hoshi, Masatoshi Tokunaga, Yukio Usui, Hideyuki Yamashita, Hiroshi Sasaki, Yasuyuki Kobayashi, island Masanori, Eiji Miyakita, Toshiro Terachi urology department bulletin 51(1): 41-44 2005
34 [clinic] sensitivity for various antimicrobial agents of gonococci derived from men's urethritis gonococcal. Hiroshi Kagami, Katsuhisa Endo, Hiroo Suzuki, Hiroshi Kiyota, Shoichi Onodera, Tokyo STD social gathering Japan Society of Chemotherapy 53(8): 483-487 2005
35 Multiple cyst-formed renal cell carcinomas which were detected with case) medical examination. Hiroshi Kagami, yuzu*tsune, Yuichi Hasegawa, Isao Ikemoto, Shoichi Onodera, Shin Egawa clinic urology department 59(2): 161-164 2005
36 Case) testicular tumors and redundant papillary renal cell carcinoma. Yasuhiro Yamaguchi, Hiroshi Kagami, Jun Miki, Yuichi Hasegawa, Isao Ikemoto, Yukihiko Oishi clinic urology department 59(3): 241-244 2005
1 Search for Biomarkers of aggressiveness in Bladder Cancer. Shin Egawa, Hidetoshi Kuruma:European Urology 50 (2006) 20-22
2 Changes in quality of life in first year after radical prostatectomy by retropubic, Laparoscopic, and perineal approach: Multi-institutional longitudinal study in Japan. Shunichi Namiki, Shin Egawa, Toshiro Terachi, Akio Matsubara, Mikio Igawa, Akito Terai, Tatsuo Tochigi, Naomasa Ioritani, Seiichi Saito, and Yoichi Arai.
Urology 67(2) 321-327 2006
3 Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland. Kazumasa Matsumoto, Shin Egawa, Takefumi Satoh, Hidetoshi Kuruma, Nobuhisa Yanagisawa and Shiro Baba International Jouronal of Urology 13(10): 1290-1295 2006
4 Surgical results of all laparoscopic bladder excision and laparotomy lymph node dissections, urinary diversion combination methods for invasive bladder cancer. nyukokei, Kazumasa Matsumoto, Takefumi Sato, circle Norio, Masatsugu Iwamura, Shin Egawa, Shiro Baba Japan Endourology&ESWL society 19(1): 103-108 2006
5 Carbohydrate chain marker RM2 antigen (β1,4-GalNAc-disialy- Lc4) of study - prostate cancer - prostate cancer of oncogene, inhibitor in serialization Department these days. Seiichi Sato 1, Shin Egawa, Akihiro Ito 1, Yoichi Arai 1 Biotherapy 20(4): 418-426 2006 (cancer and chemotherapy company)
6 Point 8) gonococcus, chlamydia infection of outpatient clinic to learn from resistant bacteria out of city which special feature is foreign, and cannot overlook and infectious disease example out of city. Hiroshi Kiyota, Shoichi Onodera, Shin Egawa
Infection and antimicrobial agent 9(3): 281-286 2006
7 Perctaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. It is 880-884 2006 Kenta Miki, Tatsuya Shimomura, Hiroki Yamada, Koichi Kishimoto, Yukihiko Ohishi, Junta Harada and Shin Egawa International Journal of Urology 13
8 Intermittent low-dose antiandrogenic medical treatment for invention progress-related prostate cancer for cure for special feature progress-related prostate cancer. Tatsuya Shimomura, Takefumi Sato, Shin Egawa urologic surgery 19(5): 595-600 2006
9 Two cases of renal cell carcinoma and renal pelvic carcinoma which occurred in ipsilateral side kidney. Hiroshi Sasaki, Toshio Hasegawa, Isao Ikemoto, Shin Egawa
It is 855-857 2006 urination bulletin 52
10 Diagnosis, treatment -Which way forward? of special Lecture II prostate cancer . Toshihiro Yamamoto, Shin Egawa urologic surgery 19 (extra edition): 315-317 2006
11 One case of hydronephrosis due to common iliac artery lump improved by case) replacement with synthetic conduit naturally. Kunitaro Sanuki, Hiroshi Omono, Hiroshi Shiono, Hiroharu Mikuriya, Haru Yamazaki Castle, Isao Ikemoto, Shin Egawa
Urologic surgery 19(10): 1257-1260 2006
12 Health care usage, botulinum toxin for overactive bladder Furuta A, Chancellor MB
It is 234-5 2006 Rev Urol 8
13 The promise ofβ3-adrenoceptor agonists to treat the overactive bladder Furuta A, Thomas CA, Higaki M, Chancellor MB, Yoshimura N, Yamaguchi O
It is 539-43 2006 Urol Clin North Am 33
1 Expression of S100A2 and S100A4 Predicts for Disease Progression and Patient Survival in Bladder Cancer. Kazumasa Matsumoto, Akira Irie, Takefumi Satoh, Junichiro Ishii, Keiichi Iwabuchi, Masatsugu Iwamura, Shin Egawa, and Shiro Baba. Urology 2007;70(3): 602-7.
2 Right testicular Necrosis and left vanishing testis in a neonate. Miyata, H. Yoshikawa, I. Ikemoto,I and Eto,Y.
It is 449-54 J Pediatr Endocri & Metabol 2007, 20.
3 Lentiviral Vectors with CMV or MHCII Promoters Administered In Vivo: Immune Reactivity Versus Persistence of Expression. Kimura T, Koya RC1), Anselmi L1), Sternini C1), Wang HJ1), Comin-Anduix B1), Prins RM1), Faure-Kumar E1), Rozengurt N1), Cui Y2), Kasahara N1), Stripecke R1) (1.UCLA, 2.Louisiana State University).
Molecular Therapy 2007, 15(7): 1390-9.
4 Lentiviral Vector-mediated Autonomous Differentiation of Mouse Bone Marrow Cells into Immunologically Potent Dendritic Cell Vaccines. Koya RC1), Kimura T, Ribas A1), Rozengurt N1), Lawson GW1), Faure-Kumar E1), Wang HJ1), Herschman H1), Kasahara N1), Stripecke R1) (1.UCLA).
Molecular Therapy 2007;15(5): 971-80.
5 Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model. Hiraoka K1), Kimura T, Logg CR1), Tai CK1), Haga K1), Lawson GW1), Kasahara N1) (1.UCLA).
Cancer Research 2007, 67(11): 5345-53.
6 Prostatic-specifinc antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy. Prostate Hayashi N, Urashima M,Ikemoto I, Kuruma H, Arai Y, Kuwao S, Baba S and Egawa S.
Cancer and Prostatic Disease 2007, 10:60-5.
7 Identification of Putative Stem Cell Markers, CD133 and CXCR4, in Human Telomerase Reverse Transcriptase-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens. Miki J, Furusato B, Hongzhan Li, Yongpeng Gu, Takahashi H, Egawa S, Isabell A. Sesterhenn, David G. McLeod, Shiv Srivastava, and Johng S. Rhim.
Cancer Research 2007:67 (7)
8 Do dysuria and sleep disorder - α blocker improve sleep disorder of BPH?― Yasuyuki Suzuki, Satoshi Kosaka, Hidenori Suzuki, Akira Furuta, Yuichi Hasegawa, Shigeru Kosugi, Hiroshi Ito 1), Masahito Kido 2), the Shin Egawa (1.Jikei University School of Medicine psychiatry, 2) Fujimura Hospital urology department.
Clinical urology department 2007, 61(12): 997-1001.
9 Effect of Eviprostat on dysuria with benign prostatic hyperplasia. Hidenori Suzuki, Toshihiro Yamamoto, Hirokazu Goto, Isao Ikemoto, Masayuki Tomita, Yasuyuki Suzuki, Shin Egawa, Hiroshi Nakajo, Takashi Hatano.
Urologic surgery 2007;20(9): 1215-20.
10 Examination about local effect of radiation therapy for renal cell carcinoma bone metastases example. Takashi Hatano, Kan Suzuki, Naruto Nagashima, Yasuhiro Yamaguchi, Kunitaro Sanuki, Koichi Kishimoto, Shin Egawa, Yoshimitsu Sunakawa, Junta Harada (The Jikei University Kashiwa Hospital radiology).
Urology department bulletin 2007, 53(10): 687-90.
11 Operation for point urology department bladder tumor of method that specialist in series rehabilitation judging from eye wants to know. Yuichi Hasegawa, Nozomi Furuta, Kunitaro Sanuki, Shin Egawa.
Journal of Clinical Rehabilitation 2007, 16(9): 798-802.
12 Operation for point urology department renal disease of method that specialist in series rehabilitation judging from eye wants to know.
Yuichi Hasegawa, Shin Egawa.
Journal of Clinical Rehabilitation 2007, 16(10): 902-5.
13 Usefulness of preoperative 99mTc- MAG3 kidney dynamics scintigraphy in kidney preservation postoperative diseased side remaining renal function evaluation. Hiroki Yamada, Takahiro Kimura, Kenta Miki, Koichi Kishimoto, Yukihiko Oishi, Yutaka Mori (Jikei University School of Medicine radiology Department,) Shin Egawa.
Urology department bulletin 2007;54(2): 89-93.
14 Way of thinking for cure for prostate cancer - high risk group― Hiroshi Sasaki, Shin Egawa.
Urologic surgery 2007, 20 (extra edition): 2443-7.
15 Comparison of effect of treatment with naftopidil and tamsulosin hydrochloride for benign prostatic hyperplasia case with overactivity-related bladder Shigeru Kosugi, Isao Ikemoto, Akira Furuta, Tatsuya Shimomura, Hiroshi Kiyota, Yasuyuki Suzuki, Koichi Kishimoto, Shin Egawa, Shinichiro Torii, Takashi Shirai, Hiroyuki Takeuchi, Kazuhiro Abe.
Japanese urology department society magazine 2007;98(5): 691-9.
16 Advances in the understanding of stress urinary incontinence and the promise of stem-cell therapy. Furuta A, Carr LK, Yoshimura N, Chancellor MB.
Rev Urol 2007, 9(3); 106-12.
17 The potential of muscle-derived stem cells for stress urinary incontinence. Furuta A, Jankowski RJ, Pruchnic R, Yoshimura N, Chancellor MB.
Expert Opin Biol Ther 2007;7(10): 1483-6.
18 The promise of stem cell therapy to restore urethral sphincter function. Furuta A, Jankowski RJ, Pruchnic R, Yoshimura N, Chancellor MB. T
Curr Urol Rep 2007;8(5): 373-8.
19 State of the art of where we are at using stem cells for stress urinary incontinence. Furuta A, Jankowski RJ, Honda M, Pruchnic R, Yoshimura N, Chancellor MB. Neurourol Urodyn 2007;26(7): 966-71
20 From situation of positioning - guidelines on laparoscopic radical prostatic extirpation making― Toshiro Terachi, Shin Egawa, Mt. Kawabata, Yukihiro Kondo, Ken Nakagawa, Masatoshi Tanaka.
Japanese EE official journal of a scientific society 2007;20(2): 150-5.
21 Update - I. of prostate cancer - basics, clinical study Fundamental researches biomarker RM2 antigen Seiichi Saito 1, Shin Egawa, enfujikikore 2, Yoichi Arai 1 (1.field of Tohoku University Graduate School medicine system graduate course urology, 2.Sendai welfare hospital pathological department).
Japanese clinic 2007, 65 (extra number 10): 117-9.
22 Battle front chronic prostatitis of lower urinary tract symptom (LUTS) medical treatment. Hiroshi Kiyota. It is 417-23 ** 2007, 61.
23 Hospital infection measures and UTI surveillance. Hiroshi Kiyota. Urologic surgery 2007, 20(S): 561-4.
24 Skill in percutaneous calculus renal crush. Hiroshi Kiyota, Nozomi Furuta, Kenta Miki, Takahiro Kimura, Shin Egawa.
Japanese EE official journal of a scientific society 2007;2(2): 186-193.
25 Endoscope (cystoscope, renal pelvis urethroscope) of urinary tract origin. Hiroshi Kiyota, Shin Egawa, Shoichi Onodera.
It is 561-6 infection defense 2007, 3.
26 "Overactivity bladder tedonna disease" Yasuyuki Suzuki. Urinary organ care 2007, 12(12): 28-30 (1164-6p).
27 Special feature) JUA prostate cancer medical treatment guidelines: Problem radiation therapy for the reading highlight and revision of the first edition. Tatsuya Shimomura, Shin Egawa.
Urologic surgery 2007;20(6): 753-9.
28 The 41st Japan lifestyle diseases (lifestyle-related disease) society: Than "education Lecture" prostate cancer - treatment battle front. Hiroki Yamada, Shin Egawa.
Lifestyle diseases and lifestyle-related disease 2007;37(5): 558-63.
29 Update of prostate cancer - basics, clinical study― Ⅱ. Treatment choice of localized prostate cancer in consideration of clinical study treatment QOL QOL
Hiroshi Sasaki, Shin Egawa.
Japanese clinic 2007, 65 (extra number 10): 593-7.
30 Urinary tract trouble hydronephrosis to meet with by medical treatment every day. Hiroshi Omono, Nozomi Furuta, Shin Egawa.
Kidney and dialysis 2007, 63(2): 216-21.
1 Haptglobin-βchain defined by monoclonal antibody RM2 as a novel
Serum marker for prostate cancer
Saito Seiichi1, Murayama Yasuko1, Pan Yuzhuo1, Taima Takenobu1, Fujimura Tsutomu2.3.4, Murayama Kimie2.3, Sadilek Marin5, Egawa Shin6, Ito Akihiro1 Ishidoya Shigeto1, Nakagawa Haruo1, Kato Msa nori1, Satoh Makoto7, E ndoh Mareyuki8, and Yoichi Arai1.
(1.Dept of Urology, Tohoku Unversity, Graduate School of Medicine
(2.Pacigic Nothwest Research Institute, Seattle, WA, 3.Dept of
Pathobiology and Microbiology, university of Washington, Seattle,WA.
4. Biomedical Research Center, Division of Proteomics and Biomolecular
Sciences, Juntendo University. 5.Dept of Chemistry, University of Washington. 6. Dept of Urology, Jikei University School of Medicine
7.Dept of Urology, Sen-dai Hospital. 8.Dept of Pathology, Tohoku University.)
Int. J. Cancer 123, 633-640 2008
2 Regional alliances and critical path of prostate cancer Haru Yamazaki Castle
Treatment 90(3) 777-782 2008
3 Examine illness; of medical promotion Department ⑫ reverse introduction / return, actually
  Prostate cancer postoperative long-term management
Haru Yamazaki Castle   Medical business Courier 4410 44-47 2008
4 How do you catch PSA recurrence after special feature / prostate cancer treatment?
Natural history of Radical Prostatectomy
Hiroshi Kiyota, Takahiro Kimura, Shin Egawa
  Urology View 6(2) 10-13 2008
5 Operation 2 in conjunction with surgical procedure) urinary incontinence Yasuyuki Suzuki
   Clinic urology department 62(6) 391-398 2008
6 Prescription experience of detorushitoru in overactivity bladder patient Yasuyuki Suzuki, Akira Furuta, Yuichi Hasegawa
New medicine and clinical 57(4); 490-497 2008
7 An example of recurrent testicular tumors having brain metastasis that case report) TIP (paclitaxel, ifomaido, cisplatin) therapy succeeded Shuichi Yanada, Hiroyuki Ito, Masayuki Tomita, Tetsuro Wada Takashi Hatano Koichi Kishimoto,     
  Shin Egawa
Urology department bulletin 54 43-46 2008
8 Staphylococcal Nuclease Domain-Containing Protein 1 as a Potential Tissue Marker for Prostate Cancer Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N, Egawa S.
American Journal of Pathology 174(6) in press.
9 Life science that special feature is new
New marker protein which recognizes prostate cancer
Hidetoshi Kuruma, Shin Egawa, Shiro Baba, Tadashi Maeda meter
Chemical industry 59(12): 51(955)-56 (960) 2008
10 Association of overactive bladder and stress urinary incontinence in rats with pudendal nerve ligation injury. Furuta A, Kita M, Suzuki Y, Egawa S, Chancellor MB, de Groat WC, Yoshimura N
Am J Physiol Regul Integr Comp Physiol 294(5); 1510-1516 2008
11 Physiological effects of human muscle-derived stem cell implantation on urethral smooth muscle function. Furuta A, Jankowski RJ, Pruchnic R, Egawa S, Yoshimura N, Chancellor MB Int. Urogynecol J 19(9); 1229-1234 2008
12 In Vitro and In Vivo Effect of Lidocaine on Rat Muscle-Derived Cells for Treatment of Stress Urinary Incontinence. Kyung Kim D, Jankowski RJ, Pruchnic R, de Miguel F, Yoshimura N, Honda M, Furuta A, Chancellor MB Urology 73(2); 437-44 2008
13 Evaluation of general remarks) residual urine measurement and urination function Akira Furuta, Yuichi Hasegawa, Yasuyuki Suzuki
Prog Med 28(6); 1407-1411 2008
14 The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomy. Hayashi N, Urashima M, Kuruma H, Arai Y, Kuwao S, Iwamura M, Egawa S.  BJU Int. 101(2): 175-80. 2008
15 Clinical analysis of the additional dosage of Eviprostat for benign prostatic hyperplasia patient having symptom resistant to α 1 receptor blockade (naftopidil) Takehito Naruoka, Yasuyuki Suzuki, Akira Furuta, Katsuhisa Endo, Shingo Sugaya, Shin Egawa
Urology department bulletin 54(5); 341-344 2008
16 Usefulness of preoperative 99mTc-MAG3 kidney dynamics scintigraphy in kidney preservation postoperative diseased side remaining renal function evaluation Hiroki Yamada, Takahiro Kimura, Kenta Miki, Koichi Kishimoto, Yukihiko Oishi, Shin Egawa, Yutaka Mori
Urology department bulletin 54, 89-93 2008
17 The outbreak condition of a patient and prevention of general remarks) special feature spina bifida and comprehensive medical care
The current situation of urinary tract management of bifid spondylosis affected child in this hospital
Yuichi Hasegawa, Yasuyuki Suzuki, Shin Egawa
Cranial nerve 33 of children, 41-42 2008
18 Anatomical knowledge and maneuver necessary for spongy body nerve preservation Jun Miki, Hiroshi Sasaki, Kenichi Hata, Takahiro Kimura, Kenta Miki, Shin Egawa
Urologic surgery 22(2) 103-108 2009
19 Know-how of special feature / outpatient department cancer chemotherapy
Real urinary organ cancer of foreign chemotherapy
Hiroshi Sasaki, Shin Egawa
Clinic and study 85(3) 57(371) -59(373) 2008
20 7)New development of special feature prostate cancer
New development laparoscope bottom nerve preservation radical prostatic extirpation of localized cancer therapy
Hiroshi Sasaki, Shin Egawa
Pharma Medica 26(8) 27-30 2008
21 Topics, progress 2008 of urologic tumor in special feature EAU/AUA/ASCO
Treatment of localized prostate cancer
Hiroshi Sasaki, Shin Egawa
Urologic surgery 21(10) 1351-1355 2008
22 Problems of grading and staging of localized prostate cancer Toshihiro Yamamoto, Shin Egawa
Urologic surgery 21(1)305 2008
23 Prostate cancer that penile metastasis was detected at the time of case report) first medical examination Yusuke Koike, Shigeru Kosugi, Toshihiro Yamamoto, Tatsuya Shimomura, Isao Ikemoto, Hiroyuki Takahashi
Clinical urology department 62(3), 251-253 2008
24 Proteomics of book, allotment) urology department domain urinary oncology Hidetoshi Kuruma.
Annual Review kidney 2008 199-206, 2008 inside and outside medicine company
25 Male sexual dysfunction with urology department disease benign prostatic hyperplasia and the treatment that we want to be careful about in particular for book, allotment) male menopause Hidetoshi Kuruma
Approach - 93-96 that obstacle - associated domain included for male menopause, 2008
Middle interest publishing company
26 Special feature urology department foreign best navigation
1. Inflammatory disorder of urinary tract, the sexual organs ■Nonspecific infectious disease [prostatitis]
9. "We strongly detect urination symptom with heat generation of 38 degrees Celsius level, and hospital visiting is patient who did. We doubted acute prostatitis. Please tell about coping and prescription."
Yasuyuki Suzuki
Clinic urology department 62(4) 38-40 2008
27 2)Special feature urology department foreign best navigation
2. Inflammatory disorder of urinary tract, the sexual organs ■Nonspecific infectious disease [prostatitis]
10. "It is 40-year-old male patient appealing for abdominal region sense of incongruity in perineum ache and urine collection. We receive some urology departments, and it is said to be chronic prostatitis and received the antimicrobial agent dosage, but symptom does not improve until now. Please tell about coping and prescription."
Yasuyuki Suzuki
Clinic urology department 62(4) 41-44 2008
1 Diagnosis and treatment of chronic prostatitis Hiroshi Kiyota
Japanese medical business Courier 4463rd 57-60 2009
2 pe snail phosphorus-resistant gonococci (Pencillin-resistant Neisseria gonorrhoeae) Hiroshi Kiyota, Shoichi Onodera
Clinic and microbe 36 (extra number) 102-104 2009
3 Way of thinking cleanliness operation of urology department operation region infection, associate cleanliness operation, pollution operation Hiroshi Kiyota
Urology department care 14(9) 36 (876)-41 (881) 2009
4 Comparison of the outcomes of magnetic resonance imaging-guided percutaneous cryoablation of renal tumors with those of partial nephrectomy. Kishimoto K, Hatano T, Furuta N, Suzuki Y, Miki K, Egawa S, Mogami T, Harada J, Kubo M.Low Temp.Med; It is 23-28 35 2, 2009
5 Comparison about surgical results of laparoscopic adrenalectomy and open operation Nozomi Furuta, Hiroshi Sasaki, Haruhisa Koide, Jun Miki, Takahiro Kimura, Shin Egawa
Clinic urology department 63(2) 157-163 2009
6 Examination of laparoscopic adrenalectomy for adrenal Pheochromocytoma Nozomi Furuta, Haruhisa Koide, Hiroshi Sasaki, Jun Miki, Takahiro Kimura, Shin Egawa.
It is 245-8 urination bulletin 2009, 55.
7 Clinical analysis about pre-clinical Cushing's syndrome postoperative steroid supplement Nozomi Furuta, Haruhisa Koide, Hiroshi Sasaki, Jun Miki, Takahiro Kimura, Shin Egawa.
Japanese urology bulletin 100(3): 479-85, 2009
8 Examination (Overactive bladder questionnaire: evaluation by OABq) of quality of life improvement effect of tamsulosin hydrochloride on overactivity bladder with benign prostatic hyperplasia Yasuyuki Suzuki, Satoshi Kosaka, Hidenori Suzuki, Akira Furuta, Mariko Honda, Yuichi Hasegawa, Takehito Naruoka, Shin Egawa.
Urologic surgery 22 10 p1293-1301 2009
9 Attempt of fast-acting evaluation of Tamsulosin dosage one week for benign prostatic hyperplasia using symptom diary Masayuki Tomita, Shin Egawa, Isao Ikemoto, Takashi Hatano, Shinichiro Kira, Toshihiko Mizuo, Hiroshi Nakajo, Hiroshi Kagami
It is 193-197 2009 urination bulletin 55
10 Basic section session 2 research aid receiving a prize problem
1. Can antibody of new prostatic marker SND1 dye cancer with clinical significance partly in immunostaining?
Hidetoshi Kuruma, Hiroko Kamata, Hiroyuki Takahashi, Koji Igarashi, Takahiro Kimura, Tatsuya Shimomura, Kenta Miki, Jun Miki, Hiroshi Sasaki, rinten*, Shin Egawa
Urologic surgery 22(8) 947-950 2009
11 Role of alpha2-adrenoceptors and glutamate mechanisms in the external urethral sphincter continence reflex in rats. Furuta A, Asano K, Egawa S, de Groat WC, Chancellor MB, Yoshimura N.
J Urol 181(3); 1467-1473 2009
12 Sex differences of autonomic nerve transmission in urine forbidden reflection at the time of rat bladder pressure Akira Furuta, Naoki Yoshimura 1), Yasuyuki Suzuki, Mariko Honda, Yusuke Koike, Shigeru Kosugi, Takehito Naruoka, Shin Egawa (1.the Pittsburgh The Jikei University urology department)
Japanese urination function official journal of a scientific society 20(2): 346-51, 2009
13 A novel androgen-dependent prostate cancer xenograft model derived from skin metastasis of a Japanese patient. Kimura T, Kiyota H, Nakata D, Masaki T, Kusaka M, Egawa S.
Prostate. 69(15): 1660-7, 2009
14 Patterns of failure and infruence of potential prognostic factors after surgery in transitional cell carcinoma of the upper urinary tract. Shimomura T, Ohtsuka N, Yamada H, Miki J, Hayashi N, Kimura T, Kuruma H,Egawa S.
It is 213-218, 2009 Int J Clin Oncology 14
15 Initial experience of all laparoscopic radical bladder evisceration Tatsuya Shimomura, Hiroshi Sasaki, Jun Miki, Hiroki Yamada, Takahiro Kimura, Nozomi Furuta, Shin Egawa
Jpn J Endourology ESWL 22:71-76 2009
16 Examination -Overactive bladder questionnaire: of quality of life improvement of tamusuron hydrochloride for overactivity bladder with benign prostatic hyperplasia Evaluation by OAB-q― Takehito Naruoka, Shin Egawa
Urologic surgery 22(10) 1293-1301 2009
17 Replication of Prostate Cancer Risk Loci in a Japanese Case-Control Association Study. Yamada H, Kathryn L.Penney, Takahashi H, Katoh T, Yamano Y, Yamamakado,M, Kimura T, Kuruma H, Kamata Y, Egawa S, Matthew L. Freedman.
JNCI 101(19): 1330-6, 2009
18 Lateral view dissection of the prostate-urethral junction to reduce positive apical margin in laparoscopic radical prostatectomy. Sasaki H, Miki J, Kimura T, Sanuki K, Miki K, Takahashi H, Egawa S.
Int J Urol. 16(8): 664-9, 2009
19 Laparoscopic nerve preservation Radical Prostatectomy -Intrafascial nerve-sparing- Hiroshi Sasaki, Shin Egawa
It is 179-183 2009 Jpn J Endourol ESWL 22
20 Effective hematoma removal method of small invention bladder tamponade Yusuke Koike, Kiyotaka Kawashima
Clinic urology department 63(11) 926-927 2009
21 Special feature Oncologic Emergency urinary obstruction Shunsuke Tuduki, Takehito Naruoka, Shin Egawa.
It is 250-255, 2009 Clinical Oncology 4
22 Approach to smoking cessation in site in cancer cooperation base Hospital business Jikei University School of Medicine The Jikei University Kashiwa Hospital local in 2008 Koichi Kishimoto.
The Jikei University Kashiwa Hospital medicine annual report 2,009:16 1:40-1
23 Medical window night urination.  Koichi Kishimoto. Chiba Medical Association magazine 2009, 61 11, 37
24 New trend of medical window benign prostatic hyperplasia Koichi Kishimoto. Chiba Medical Association magazine 2010 March
25 Disease of condition of a patient and disease B) causative tissue of clinic, excretion disorder of excretion disorder Yasuyuki Suzuki
Modern Physician 29 11 p1543-1545 2009 new medical publishing company
26 "It is pathophysiology of urinary incontinence skin, the excretion care battle front thirteenth Yasuyuki Suzuki.
Nursing, toe D p10-13 24 4-2009 day book nursing publication associations
27 Alpha2-Adrenoceptor as a new target for stress urinary incontinence Furuta A, Naruoka T, Suzuki Y, Egawa S, Erickson VL, Chancellor MB, Yoshimura N.
LUTS 1, S26-9 2009
28 Adaptation and limit adjuvant endocrine therapy of various cures to think about with risk  
29 Vesicovaginal fistula, ureterovaginal fistula Takehito Naruoka, Shin Egawa
Medicine and pharmacy 62(5) 843-851 2009
30 Anatomical knowledge and maneuver necessary for spongy body nerve preservation Jun Miki, Hiroshi Sasaki, Kenichi Hata, Takahiro Kimura, Kenta Miki, Shin Egawa
Urologic surgery 22(2), 103-108 2009
31 Radiotherapy for special feature urinary tract genital cancer
Radiation therapy effect measurement for prostate cancer: PSA bounce
Masahito Kido, Kenta Miki, Manabu Aoki, Shin Egawa
Urology View 7(6) 51-53 2009
1 Study on bother in benign prostatic hyperplasia case judging from IPSS-QOL. Isao Ikemoto, Takehito Naruoka, Kiyokazu Umezu, Norishige Otsuka, Masaya Murakami, Shigeru Kosugi, Takashi Shirai.
Urologic surgery 2010, 23(9): 1291-8.
2 Two cases of seriously ill kidney outside symptom where Silo closure was useful. Koichi Kishimoto, Takashi Hatano, Shin Egawa, Akira Miyake 1), Kazuyoshi Ohashi 1), Tsutomu Koyama 1)
(1.The Jikei University Kashiwa Hospital first aid part).
Clinical urology department 2010, 64(13): 1017-20)
3 From situation of prostate cancer regional medicine cooperation - university hospital― Haru Yamazaki Castle
Urologic surgery 2010, 23(6): 781-786
4 Female urethra malignant melanoma that case) high dose rate intracavitary irradiation was effective. Yasuyuki Suzuki, Akira Furuta, Takehito Naruoka, Mariko Honda, Shin Egawa, Chihiro Kanehira.
Clinic urology department 2010, 65 (1) 65-8.
5 Usefulness of index of attempt - will of own strength urination function early evaluation of patients with urinary retention old for acute disease convalescence― Yasuyuki Suzuki, Satoshi Kosaka, Akira Furuta, Mariko Honda, Shin Egawa.
Japanese wound, ostomy, incontinence management official journal of a scientific society 2010:14 (3), 252-7
6 Clinical analysis of five adrenal myelolipoma. Nozomi Furuta, Mariko Honda, Hiroyuki Inaba, Yusuke Koike, Norishige Otsuka, Toshihiro Yamamoto, Hiroshi Sasaki, rinten*, Takahiro Kimura, Shin Egawa
Clinical urology department 2010, 64(2): 155-9.
7 Chronological changes after MRI-guided percutaneous cryotherapy for small renal tumors. Takashi Hatano, Tadashi Uno, Syunsuke Tsuduki, Yusuke Koike, Ken-ichi Hata, Koichi Kishimoto, Takuji Mogami, Yoshimitsu Sunakawa, Junta Harada, Shin Egawa.
Low Temperature Medicine 2010, 36(4): 103-108.
8 Transperineal prostate Brachytherapy, using I-125 seed with or without adjuvant androgen Deprivation, in patients with intermediate-risk prostate cancer: Study protocol for a phase III, multicenter, randomized, controlled Trial. Miki K, Kiba T, Sasaki H, Kido M, Aoki M,Takahashi H, Miyakoda K,Dokiya T, Yamanaka H, Fukushima M, Egawa S.
BMC Cancer 2010, 10:52.
9 Invention of invention in laparoscopic total prostatectomy to be useful for special feature open surgery and the effect apex processing. Kenta Miki.
Urologic surgery 2010, 23(11): 1547-8.
10 Examination of usefulness of sorifenashin in spinal cord injury and cerebral infarction rat causing neuropathic overactivity bladder. Akira Furuta, Takafumi Yanagisawa, Mariko Honda, Gen Ishii, Yusuke Koike, Takehito Naruoka, Yasuyuki Suzuki, Shin Egawa.
Japanese urination function official journal of a scientific society 2010, 21(2): 320-4.
11 Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer Using Renilla and Gaussia lucigerases. Kimura T, Hiraoka K, Kasahara N, Logg CR.
J Gene Med. 2010, 12(6): 528-37.
12 Neonatal gene transfer using lentiviral vector for murine Pompe disease: long-term expression and glycogen reduction. Kyosen SO (Division of Gene Therapy, Institution of DNA medicine), Iizuka S (Division of Gene Therapy, Institution of DNA medicine), Kobayashi H (Division of Gene Therapy, Institution of DNA medicine), Kimura T, Fukuda T (Division of Gene Therapy, Institution of DNA medicine), Shen J (Division of Gene Therapy, Institution of DNA medicine), Shimada Y (Division of Gene Therapy, Institution of DNA medicine), Ida H (Department of Pediatrics), Eto Y (Division of Gene Therapy, Institution of DNA medicine), Ohashi T (Division of Gene Therapy, Institution of DNA medicine).
Gene Therapy 2010;17(4): 521-3 2010
13 Transduction of Humanized Liver Tissue in Chimeric Mice via
High-capacity Adenovirus- Lentivirus Hybrid Vector.
Kubo S (UCLA), Kataoka M (UCLA), Tateno C (UCLA), Yoshizato K (UCLA), Kawasaki Y (UCLA), Kimura T, Faure-Kumar E (UCLA), Palmer DJ (UCLA), Ng P (UCLA), Okamura H (UCLA), Kasahara N (UCLA). In Vivo Stable
Human Gene Therapy 2010;1(1): 40-50
14 Investigations of prostate epithelial stem cells and prostate cancer
Stem cells.
Miki J,, ...
Int J Urol. 2010;17(2): 139-7.
15 Upfront transection and subsequent ligation of the dorsal vein complex
During laparoscopic radical prostatectomy.
Sasaki H, Miki J, Kimura T, Yamamoto T, Koike Y, Miki K and Egawa S.
Int. J. Urol. It is 960-1 2010, 17.
16 Prostate cancer regional alliances critical path. Haru Yamazaki Castle.
It is 24-27 medical Qol 2010, 188.
17 The first step "prevention of special feature sexually transmitted disease (STI) medical treatment of mini-lecture sexually transmitted disease" Hiroshi Kiyota
Clinical training practice 2010, 7(2): 76-7.
18 Benign prostatic hyperplasia and dysuria. Yasuyuki Suzuki, Akira Furuta.
Laboratory study 2010, 54(7): 739-46.
19 Dysuria "prostatic hypertrophy and dysuria" Yasuyuki Suzuki, Akira Furuta.
Laboratory study 2010:54 (7), 739-46
20 "Technical Q&A of urination management that care turns into from today" Chapter 9 disease, treatment and urination management 9-1 "basic knowledge of urination management"
Yasuyuki Suzuki, Akira Furuta.
It is 238-43 urinary organ care 2010, 177
21 Basic knowledge Vol 6 OAB (overactivity bladder) for patient compliance instruction which is good than we ask specialist + expert Yasuyuki Suzuki.
Credentials 2010, 23 (August issue): 20-2.
22 The prevention, actions to be taken for the rectal damage in troubleshooting) laparoscopic Radical Prostatectomy in the eleventh serialization urology department domain. Jun Miki, Shin Egawa.
Urologic surgery 2010, 23(7): 945-7
23 Differential Roles of M2 and M3 Muscarinic Receptor Subtypes in Modulation of Bladder Afferent Activity in Rats. Matsumoto Y, Miyazato M, Furuta A, Torimoto K, Hirao Y, Chancellor MB, Yoshimura N.
Urology 2010, 75(4): 862-7.
24 Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotoyped lebtiviral vectors. Matsumoto H, Kimura T, Haga K, Kasahara N, Anton P, Mc Gowan I.
BMC Gastroenterol. 2010, 11:44.
25 Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting. Nickel JC, Furuta A, Chancellor MB, Roehrborn CG, Assimos DG, Shapiro E, Brawer MK.
Rev Urol 2010, 12 (2-3): 134-46.
26 One case of localized ureter amyloidosis diagnosed with sense of incongruity at frank haematuria and urination Urology department surgery, 2011, 24(3), P373-376
Kenichi Hata, Koichi Kishimoto, Ken Marumo
1 Reflections on attempted Anglo-Japanese Collaboration trial for men with prostate cancer. 1) Matthew R Sydes1, Egawa S, Karen Sanders1, Claire Amos1, Noel Clarke2, Kimura T and Nicholas D James3 (1.Cancer Group, Medical Research Coundil Clinical Trials Unit, London. 2.Department of Urology, The Christie and Salford Royal Hospitals Foundations Trusts, Manchester, 3.School of Cancer Sciences, University of Birmingham, Birmingham, UK).
Int J Urol 2011;18(8): 553-5.
2 Japanese guidance for clinical research of antimicrobial agaents on Urogenital infections: the first edition. 2) Yasuda M, Takahashi S, Kiyota H, Ishikawa K, Takahashi A, Yamamoto S, Arakawa S, Monden K, Muratani T, Hamasuna R, Hayami H, Mastumoto T.
It is 579-94 J Infect Chemother 2011, 17.
3 The nationwide study of bacterial pathogens assicuated with urinary tract infections conducted by Japanese Society of Chemotherapy. Ishikawa K, Matsumoto T, Yasuda M, Uehara S, Muratani T, Yagisawa M, Sato J, Niki Y, Totsuka K, Sunakawa K, Hanaki H, Hattori R, Terada M, Kizuki T, Maruo A, Morita K, Ogasawara K, Takahashi Y, Matsuda K, Hirose T, Miyao N, Hayashi T, Takeyama K, Kiyota H, Tomoita M, Yusu H, Koide H, Kimura S.
It is 126-38 J Infet Chemother 2011, 17.
4 Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo. Thomas C, Zoubeidi A, Kuruma H, Fazli L, Lamoureux F, Baraldi E, Monia BP, MacLeod AR, Thüroff JW, Gleave ME (The Vancuver Prostate Centre).
Mol Cancer Ther. 2011;10(2): 347-59.
5 A novel HSP90 inhibiter delayts castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis. Lamoureux F, Thomas C, Yin MJ, Kuruma H, Fazli L, Gleave ME, Zoubeidi A. (The Vancuver Prostate Centre).
Clinical Cancer Res. 2011, 17(8): 2301-13.
6 Discovery of aryloxy tetramethlcyclobutanes as novel androgen receptor antagonists. Guo C, Linton A, Kephart S, Ornelas M, Pairish M, Gonzalez J, Greasley S, Nagata A, Burke BJ, Edwards M, Hosea N, Kang P, Hu W, Engebrestsen J, Briere D, Shi M, Gukasyan H, Richardson P, Dack K, Underwood T, Johnson P, Morell A, Felstead R, Kuruma H, Matsimoto H, Zoubeidi A, Gleave M, Los G, Fanjul AN (Pfizer Worldwide).
J Med Chem. 2011;54(21): 7693-704.
7 Urethral compensatory mechanisms to maintain urinary continence after pudendal nerve injury in female rats. Furuta A, Suzuki Y, Asano K, William C de Groat, Egawa S, Yoshimura N.
It is 963-70 Int Urogynecol J 2011, 22
8 Time-dependent changes in bladder function and bladder plantar Sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus. Furuta A, Suzuki Y, Honde M, Koike Y, Naruoka T, Asano K, Michael Chancellor, Egawa S and Yoshimura N.
It is 306-10 BJU Int 2011, 109.
9 Analysis of sensitivity and cefixime low sensitive strain penA gene for various antimicrobial agents of Nesseria gonorrhoeae derived from men's urethritis gonococcal. Shoichi Onodera, Hiroshi Kiyota, Katsuhisa Endo, Hiroyuki Ito, Takahide Hosobe, Kunitaro Sanuki, Masaki Yoshida, Mariko Takakura, Masahiro Takahata.
Japan Society of Chemotherapy magazine 2011;59(1): 17-24.
10 Examination for the effectiveness of naftopidil for BPH/male LUTS case judging from improvement of poverty degree. Isao Ikemoto, Takehito Naruoka, Kiyokazu Umezu, Norishige Otsuka, Kojiro Tashiro, Shigeru Kosugi.
Clinical urology department 2011;65(5): 315-21.
11 Usefulness evaluation - of sorifenashin for examination - indafenashin effect on woman overactivity-related bladder insufficiency example of drug change having impending urinary incontinence. 3) Yasuyuki Suzuki, Akira Furuta, Mariko Honda, Gen Ishii, Ryuji Tabata, Kan Suzuki, Takafumi Yanagisawa, Takahiro Kimura, Nozomi Furuta, Takehito Naruoka, Hidenori Suzuki, Satoshi Kosaka, Shin Egawa.
Urologic surgery 2011, 24(7): 1173-80.
12 Comparison - of sensitivity - 2006 through 2010 isolate for various antimicrobial agents of gonococci derived from men's urethritis gonococcal. Katsuhisa Endo, Shoichi Onodera, Hiroshi Kiyota, Hiroo Suzuki, Takahide Hosobe, Kento Naruoka, Kunitaro Sanuki.
Japan Society of Chemotherapy magazine 2011, 59(3): 308-12.
13 Establishment of cystitis interstitial-like model by sensitization between organ in pelvis through TRPA1 stimulation of large intestine, the uterus. Akira Furuta, Yasuyuki Suzuki, Takafumi Yanagisawa, Mariko Honda, Yusuke Koike, Kan Suzuki, Takehito Naruoka, rinten*, Shin Egawa.
Japanese urination function official journal of a scientific society 2011, 22(2): 283-9.
14 Mainly on surgical results - QOL in laparoscopic Radical Prostatectomy -. Takahiro Kimura, Hiroshi Sasaki, Jun Miki, Toshihiro Yamamoto, Shin Egawa.
Japanese Journal of Endourology 2011;24:49-54.
15 Cancer stem cell identification and elucidation in prostate cancer. Jun Miki, Hiroshi Sasaki, Takahiro Kimura, Shin Egawa.
Urologic surgery 2011, 24(8): 1239-40
16 Urination symptom of chronic prostatitis. Hiroshi Kiyota.
General clinical 2011, 60(2): 299-301.
17 The ninth LUTS Expert Forum record special Lecture 2 ICS-IUGA 2010 latest report: From topic of clinical study. Yasuyuki Suzuki.
Urologic surgery 2011, 24(7): 1214-7.
18 Overactivity bladder. Yasuyuki Suzuki.
Urinary organ care 2011, 16(4): 32-3(356-7)
19 Metabolic syndrome and overactivity bladder. Yasuyuki Suzuki.
Dysuria practice 2011, 71st 19(1): 7-10.
20 Overactivity bladder. Yasuyuki Suzuki.
Urology department medical treatment guide (Yoji Katsuoka editing) 2011, 155-7 kinhodo
21 How should we answer trouble of patient? Special feature "question Q&A to be asked about by urology department patient in secret" Yasuyuki Suzuki.
Urinary organ care 2011;16(3): 42-4.
22 Strategies for treatment of high-risk prostate cancer judging from surgical therapy strategic domestic and foreign guidelines for special feature high risk prostate cancer. (Treatment Guidelines for high risk prostate cancer) Kenta Miki.
Urologic surgery 2011, 24(2): 125-8.
23 The latest diagnostic ultrasound data book prostate Kenta Miki.
Clinical image separate volume 2011 27 4 216-9.
24 Disease, treatment, care 16 of the quick master urology department radiation therapy (external irradiation and internal exposure). Kenta Miki.
Urinary organ care 2011 16 4 50-51.
25 Progress of treatment surgical cure surgical cure of update -II clinic prostate cancer of prostate cancer (the second edition) - basics, clinical study Kenta Miki.
Japanese clinical 2011 69 extra number 5 330-333.
26 Identification of new biomarker by biomarker proteome analysis of basic prostate cancer. rinten*, Hidetoshi Kuruma, Shin Egawa.
Japanese clinic 2011, 69 (extra number): 140-4.
27 ⅡWhat should celoscope operation retroperitoneum mirror bottom radical prostatic extirpation Intra-fascial nerve sparing do? Hiroki Yamada, Shin Egawa.
** 2011, 65(4): 126-8.
28 ⅡCeloscope operation retroperitoneum mirror bottom radical prostatic extirpation
We cannot distinguish border of the prostate from bladder
Hiroki Yamada, Shin Egawa.
** 2011, 65(4): 132.
29 Dissection of prostatic apex that we saw with endoscope. Hiroki Yamada, Shin Egawa.
It is 57-62 dysuria practice 2011, 3.
1 Small cancer in solitary kidney: partial nephrectomy vs. MRI-guided Percutaneous cryoablation. Hatano T, Ishii G, Endo K, Mogami T, Sunakawa Y, Harada J, Kisimoto K And Egawa S.
Low Temperature Medicine 2012;38(3): 69-72.
2 A novel anti-androgen, Compound 30, suppresses castration-resistant and MDV3100-registant prostate cancer growth in vitro and in vivo. Kuruma H, Matusumoto H, Shiota M, Jeninifer Bishop, Francois Lamoureux, Chrintian Thomas, David Briere, Gerrit Los, Martin Gleave, Andrea Fanjul,and Amina Zoubeidi.
It is 567-76 Molecular Cancer Thefapeutics 2013, 12.
3 Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: Implication for the pathogenesis of interstitial cystitis/bladder pain symdrome. Furuta A, Suzuki Y, Hayashi N, Egawa S and Yoshimura N.
Int. J. It is 429-36 Urol 2012, 19.
4 Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Akamatsu S, Takata R, Christopher A Haiman, Takahashi A, Inoue T, Kubo M, Furihata M, Kamatani N, Inazawa J, Gary K Chen, Loic Le Marchand, Katoh T, Yamano Y, Yamakado M, Takahashi H, Yamada H, Egawa S, Fujioka T, Brian E Henderson, Habuchi T, Ogawa O, Nakamura Y & Nakagawa H.
Nature Genetics 2012;44(4): 426-9.
5 Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients. Kimura T, Furusato B, Miki J, Yamamoto T, Hayashi N, Takahashi H, Kamata Y, van Leenders GJ, Visakorpi T, Egawa S.
Pathology International 2012, 62(11): 742-8v; 62(11): 742-8.
6 Pathophysiology of urinary incontinence in murine models. Koike Y, Furuta A, Suzuki Y, Honda M, Naruoka T, Asano K, Egawa S, Yoshimura N.
Int J Urol 2013, 20, 64-71
7 Special feature / sutoppuobuza sexually transmitted disease. Trend of sexually transmitted disease in our country Shoichi Onodera.
Clinic and study 2012, 89(7): 1-8.
8 Other than treatment - pharmacotherapy for chronic prostatitis / chronicity pelvis ache syndrome Hiroshi Kiyota.
Clinical urology department 2012, 66(11): 863-8.
9 Latest diagnosis and treatment for workshop - early renal cancer. Open MRI guide bottom percutaneous freeze treatment Takashi Hatano.
Urologic surgery 2012, 25 (extra edition): 1021-3.
10 Possibility cryogenic surgery of low involvement treatment for narrow path renal tumor Takashi Hatano.
Urologic surgery 2012, 25(7): 1457-61.
11 Symposium 6 - prostate cancer: Strategies for treatment - of high-risk early cancer
2.Treatment result of LDR brachytherapy for high-risk prostate cancer.
Kenta Miki.
Urologic surgery 2012, 25 (extra edition): 959-61.
12 Participation of TRPA1 channel in acrolein-induced cystitis interstitial-like symptom. Akira Furuta, Yasuyuki Suzuki, Yukiko Hiramoto, Yasutoshi Yoshiyama, Mariko Honda, Yusuke Koike, Takehito Naruoka, rinten*, Shin Egawa.
Japanese urination function official journal of a scientific society 2012, 23, 288-94.
13 Relief iodine-125 for local recurrence after radiotherapy for localized prostate cancer
Initial experience of LDR
Yusuke Koike, Masaki Shinbo, Koichi Inoue, Hiroyuki Inaba, henyasusumi, Kiyotaka Kawashima
Urologic surgery 2012:25 (4): 713-7.
14 The change and the current situation of total prostatectomy Jun Miki, Shin Egawa.
Urologic surgery 2012, 25 (in particular): 547-50.
15 One case of bladder cancer which resulted in isolated adrenal metastasis. Is full of Mariko Honda, Kan Suzuki, Hidetoshi Kuruma, Shin Egawa, Shingo Sugaya, Naoya Kondo, Mitsufumi Abe, tall skirting, Yuichi Hasegawa.
Urination bulletin 2012, 58(9): 495-7
16 The Jikei University School of Medicine and clinical picture in prostate cancer between associated facilities and investigation about diagnosis. Masaya Murakami, Shingo Sugaya, Takahiro Kimura, Nobuki Kato, Shuichi Yanada, Hiroshi Nakajo, Katsuhisa Endo, Hiroo Suzuki, Hirokazu Goto, Kazuya Tashiro, Hiroshi Kiyota, Koichi Kishimoto, Isao Ikemoto, Naoya Kondo, Shin Egawa.
It is 17-23 Jikei University School of Medicine 2013, 128.
17 One case of placenta percreta in acknowledgment of bladder permeation Takafumi Yanagisawa, Akira Furuta, Shin Egawa, Tadao Tanaka.
It is 283-6 urination bulletin 2012, 58.
18 Detailed exposition) urogenital infection. Hiroshi Kiyota.
Diagnosis and treatment 2012, 100(3): 393-401.
19 Problems of asymptomatic sexually transmitted disease Hiroshi Kiyota.
Astellas Pharma Inc. "infectious disease" 2012, 42(3) (consecutive number of volumes 245th): 15-26.
20 Choice of bedside trouble actions to be taken antimicrobial agent Hiroshi Kiyota.
21 Prostate cancer toward tomorrow gives medical care from today Kenta Miki, Shin Egawa.
Current Therapy 2012;30(9): 94-98.
22 Urine prohibition mechanism that we learned from urinary incontinence model animal. Akira Furuta, Shin Egawa, Yasuyuki Suzuki, Naoki Yoshimura.
Urology Today 2012, 19, 34-8.
23 Point of revision of effect of treatment criteria Gen Ishii, Shin Egawa.
Urologic surgery 2012, 25(6): 1279-82.
24 The latest biomarker in prostate cancer Gen Ishii, Takahiro Kimura, Hidetoshi Kuruma, Shin Egawa.
nichihon*sho 2012, 70(5): 828-32.
1 Loss of PTEN is associated with aggressive behavior in ERG positive prostate cancer. Leinonen KA, Saramaki OR, Furusato B, Kimura T, Takahashi H, Egawa S,Suzuki H, Keiger K, Hahm SH, Isaacs WB, Tolonen TT, Stenman UH, Tmmela TL, Nykter M, Bova GS, Visakorpi T.
Cancer Epidemiol Biomarkers Prev. 2013 ;105(14): 1050-8.
2 Prevalence of Prostate Cancer on Autopsy:Cross-Sectional Study on Unscreened Caucasian and Asian Men. Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, Takahashi H,Kuk C, Kovylina M, Aldaoud N, Fleshner N, Finelli A, Klotz L, Sykes J,Lockwood G, van der Kwast TH.
J Natl Cancer Inst. 2013, 105 (14): 1050-8.
3 Nationwaide surveillance of the antimicrobial susceptibility of Nesseria gonorrhoeae from male urethritis in Japan. Hamasuna R, Yasuda M, Ishikawa K, Uehara K, Takahashi S, Kiyota H, Egawa S, et al.
It is 571-8 J Infect Chemother 2013, 19.
4 Shirinkage of Prostate Volume in Sunitinib-tereated Patients with Renal Cell Carcinoma. Hatano T, Ishii G, Endo K, Kishimoto K and Egawa S.
Jpn J Clin Oncol 2013;43(12): 1282-5
5 Identification of HLA ClassI-binding Peptides Derived from Unique Cancer-associated Proteins by Mass Spectrometric Analysis. Kamata Y, Kuhara A, Iwamoto T, Hayashi K, Koido S, Kimura T, Egawa S and Homma S.
It is 1853-60 Anticancer Research 2013, 33.
6 Pathophysiology of urinary incontinence in murine models. Koike Y, Furuta A, Suzuki Y, Honda M, Naruoka T, Asano K, Egawa S, Yoshimura N.
Int J Urol 2013, 20: 64-71
7 Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration. Shiota M, Yokomizo A, Fujimoto N, Kuruma H, Naito S.
Curr Cancer Drug Targets. 2013 ;13(4): 444-59.
8 A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo. Kuruma H, Matsumoto H, Shiota M, Bishop J, Lamoureux F, Thomas C, Briere D, Los G, Gleave M, Fanjul A, Zoubeidi A.
Mol Cancer Ther. 2013;12(5): 567-76.
9 Words of Wisdom: re: international variation in prostate cancer incidence and mortality rates. Kuruma H, Egawa S.
Eur Urol. 2013;63(3): 583-4.  Related citations
10 Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. Sasaki H, Kido M, Miki K, Kuruma H, Takahashi H, Aoki M, Egawa S.
Int J Urol. On line 2013
11 Laparoscopic Radical Prostatectomy: Treatment result for 10 years. Kohei Mochizuki, Kenichi Tabata, Takefumi Sato, Shinji Kurosaka, Daisuke Ishii, Morihiro Nishi, Ryota Maeyama, Kentaro Kobayashi, Shin Egawa, Shiro Baba, Masatsugu Iwamura.
It is 104-9 Japanese urinary organ endoscopy bulletin 2013, 26
12 Endoscope surgery education from resident in connection with technical authorized system in study. Yoshiro Ishibashi, Takeyuki Misawa, Nobuo Omura, Masanao Okuma, Shuichi Ashiduka, Makoto Odaka, Sugimoto fairness, Hiroki Yamada, Hideyuki Kashiwagi, Toshiaki Morikawa, Katsuhiko Yanaga, Aikou Okamoto, Shin Egawa, Hiroshi Moriyama.
Japanese association of surgery system official journal of a scientific society 2013, 38(2): 235-42.
13 Multi-facilities collaborative investigation about perioperative infection prophylaxis guidelines in urology department domain UTI combination workshop) Koichiro Wada, Shinya Uehara, Shinichiro Kira, Masahiro Matsumoto, Takehiko Syou, Yuichiro Kurimura, Jiro Hashimoto, Takehisa Uehara, Takashi Yamane, Sojun Kanamaru, Yoshikazu Togo, Rikiya Taoka, Akira Takahashi, Yusuke Yamada, Akira Yokomizo, Mitsuru Yasuda, Hitoshi Tanaka, Ryouichi Hamasuna, Satoshi Takahashi, Hiroshi Hayami, Toyohiko Watanabe, Koichi Kadota, Hiroshi Kiyota, Takashi Deguchi, Seiji Naito, Yasushi Tsukamoto, Souichi Arakawa, Masato Fujisawa, Shingo Yamamoto, Hiromi Kumon, Tetsuro Matsumoto
Day urination bulletin (Jpn.J.Urol) 2013, 104 (3): 505-12
14 It is infectious disease V. according to - lower organ including until monopathy infectious from infectious disease syndrome (the second edition) - syndrome Urinary tract infection, male genital infection pyelonephritis Hiroshi Kiyota.
Syndrome series 2013 according to Separate volume Nippon-Rinsho frontier, 25:363-8
15 Examination about primary aldosteronism postoperative hypertensive prognosis.
(The Prevalence of Hypertention after Adrenalectomy in Patients with Primary Aldosteronism.)
Nozomi Furuta, Shigehiro Bando, Toshihiro Yamamoto, Takehito Naruoka, Hiroki Yamada, rinten*, Takahiro Kimura, Koji Asano, Shin Egawa.
Urination bulletin 2013, 225-9
16 MR seeing through guide bottom percutaneous cryogenic surgery for narrow path renal cancer. Takashi Hatano.
It is 163-9 Japanese Journal of Endourology 2013, 26
17 Harmful phenomenon with treatment: Kind of urinary tract and harmful phenomenon in rectum to be generated in the close in early stage and the incidence. In addition, the prevention and cure Kenta Miki.
It is 182-3 Japanese Journal of Endourology 2013, 26
18 The condition of a patient of cystitis interstitial (IC/BPS)  Akira Furuta, Yusuke Koike, Yasuyuki Suzuki, Shin Egawa.
Urologic surgery 2013, 26 (extra edition): 663-6
19 Clinical analysis in 20 renal injury. Kenichi Hata, Tadashi Uno, Shunsuke Tuduki, Yusuke Koike, Takashi Hatano, Koichi Kishimoto, Akira Miyake, Kei Otani, Shin Egawa.
Urologic surgery 2013, 26(6): 989-93
20 About the change of radiotherapy Gen Ishii, Shin Egawa.
Urologic surgery 2013, 26(5): 789-91
1 Prevalence of inflammation and benign prostatic hyperplesia on autopsy in Asian and Caucasian men. Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, Takahashi H,Kuk C, Kovylina M,Aldaoud N, Fleshner N, Finelli A, Klotz L, Lockwood G,Sykes J, Kwast Tv.
Eur Urol 2014 Oct; 66(4): 619-22
2 Cross-Sensitization mechanisums between colon and bladder via transient receptor potential A1 stimulation in rats. Furuta A, Suzuki Y, Naruoka T, Asano K, Egawa S, Yoshimura N.
It is 1575-81 In Urogynecol J 2014, 25.
3 Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients. Kimura T, Kido M, Miki K, Yamamoto T, Sasaki H, Kuruma H, Hayashi N,Takahashi H, Aoki M and Egawa S.
It is 473-478 International Journal of Urology 2014, 21
4 BMI is associated with larger index tumors and worse outcome After radical prostatectomy. Hayashi N, Matsushima M, Kido M, Naruoka T, Furuta A, Furuta N, Takahashi H, Egawa S.
Prostate Cancer Prostatic Dis. 2014 (sep); 17(3): 233-7
5 Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. Sasaki H, Kido M, Miki K, Kuruma H, Takahashi H, Aoki M and Egawa S.
It is 572-577 International Journal of Urology 2014, 21.
6 Pulmonary metastases after low-dose-rate brachytherapy for localized prostate cancer. Kido M, Kuruma H, Sasaki H, Miki K, Aoki M, Kimura T, Takahashi H, Kanehira C, Egawa S.
Korean J Urol. 2014 May; 55(5): 309-14
7 Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? Sugimoto M, Hirama H, Yamaguchi A, Koga H, Hashine K, Ninomiya I, Shinohara N, Maruyama S, Egawa S, Sasaki H, Kakehi Y; The PRIAS-JAPAN study group.
From an interim analysis of PRIAS-JAPAN. World J Urol 2014,
8 Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy). Aoki M, Miki K, Kido M, Sasaki H, Nakamura W, Kijima Y, Kobayashi M, Egawa S, Kanehira C.
J Radiat Res 2,014:55 (3): 527-32
9 Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis. Matsumoto H, Haga K, Ohno I, Hiraoka K, Kimura T, Hermann K, Kasahara N, Anton P, McGowan I.
BMC Gastroenterol 2014, 8, 14:68
10 Six cases of kidney collecting tubules cancer Takehito Naruoka, Nozomi Furuta, Takashi Hatano, Jun Miki, Masaya Murakami, Shin Egawa.
Urination bulletin 2014 Sep., 60(6): 427-430
11 Video discussion: About operation adaptation of Radical Prostatectomy - robot age, method choice – Hiroshi Sasaki, Shin Egawa.
Minimum wound urinary organ endoscope society magazine 2014,
12 Examination of the detection situation of substrate specific expansion type β - lactamase-producing Escherichia coli derived from urinary tract and chemical sensitivity. Koji Yoshikawa, Jun Moritake, Kan Suzuki, Shinichiro Kira, Haruhisa Koide, Hiroshi Kiyota, Hori Seiji.
Japan Society of Chemotherapy 2014, 62(2): 198-203
13 One case of urethra condyloma acuminatum after urethra plasty for hypospadias. Kan Suzuki, Haruhisa Koide, Shinichiro Kira, Jun Moritake, Yukiko Hiramoto, Hiroshi Kiyota, Shin Egawa.
Infectious disease studies magazine 2014, 88(3): 288-90
14 100 mg of sitafloxacin1 time throws, twice a day for acute simple cystitis, multi-facilities collaborative investigation about the effectiveness of the three days dosage method Kan Suzuki, Haruhisa Koide, Shinichiro Kira, Jun Moritake, Yukiko Hiramoto, Hiroshi Kiyota, Shin Egawa, Kamon Shimizu, Chizuru Arisawa, Yasumasa Iimura, Naoko Kawamura
Japan Society of Chemotherapy magazine 2014, 62(4): 494-499
15 An example that the akishichinibu dosage of second line showed fruition to for metastatic renal cancer of papillary type2 which was Sunitinib refractoriness. Gen Ishii, Takashi Hatano, Katsuhisa Endo, Kunihiko Seki, Hiroki Yamada, Takahiro Kimura, Shin Egawa.
Day urination bulletin 2014, 105 (3): 129-33
16 One case that was treated effectively with dosekitakiseru for metastasis in prostatic small cell carcinoma pelvis. Gen Ishii, Hiroshi Omono, Kanako Kasai, Kenichi Hata, Takahiro Kimura, Masayasu Suzuki, Shin Egawa.
It is 641-4 urinary organ 2014 required, 60
17 Clinical analysis of injection therapy in BCG bladder for High Grade muscular layer non-permeation-related bladder cancer in our university hospital Shunsuke Tuduki, Jun Miki, Hideomi Nishikawa, Takafumi Yanagisawa, Shigehiro Bando, Tatsuya Shimomura, Koichi Kishimoto, Shin Egawa.
Urologic surgery 2014, 27(3): 354-355
18 One case that huge subcutaneous haematoma-related shock with goserelin acetate depot preparation hypodermic injection produced. Kojiro Tashiro, Shoji Kimura, Takehito Naruoka, Nozomi Furuta, Shin Egawa.
Urination bulletin 2014;60(9): 455-8
19 One case of tuberculous epididymitis that developed after the injection therapy in BCG bladder. Masashi Uno, Susumu Numasaki, Nobuki Kato, Shin Egawa.
Urination bulletin 2014, 60(6): 291-4
20 Radical bladder total extirpation, one case that enforced percutaneous BCG perfusion therapy for ileal new bladder enlargement postoperative upper urinary tract CIS. Koki Obayashi, Jun Miki, Kanako Kasai, Kojiro Tashiro, Shunsuke Tuduki, Shigehiro Bando, Gen Ishii, Kan Suzuki, Takahiro Kimura, Koichi Kishimoto, Shin Egawa.
Urination bulletin 2014;60(9): 443-6
1 Clinical Evaluation of Primary Aldsteronism with subclinical cushing' s syndrome. Furuta N, Naruoka T, Igarashi T, Bando S, Yamada H, Kimura T, Egawa S.
It is 185-90 Hinyokika kiyo 2015, 61
2 Noradrenergic Mechanisms Contorolling Urethra Smooth
And Striated Muscle Function in Urethral Continence Reflex in Rats.
Furuta Akira, Suzuki Yasuyuki, Kimura Shoji, Asano Koji, Egawa Shin, Yoshimura Naoki.
It is 155-61 Lower Urinary Tract Symptoms 2015, 7.
3 Video-urodynamic effects of mirabegron, aβ3-adrenoceptor agonist, in patients with low-compliance bladder. Kamei J, Furuta A, Akiyama Y, Niimi A, Ichihara K, Fujimura T, Fukuhara H, Kume H, Homma Y, Igawa Y.
It is 956-61 Int J Urol 2015, 22
4 Gonadotropin-releasing hormone
Antagonist:A real advantage?
Kimura T, Sasaki H, Akazawa K, Egawa S.
Urol Oncol 2015 jul; 33(7)322-8
5 Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer. Nozawa M, Mukai H, Takahashi S, Uemura H, Kosaka T, Onozawa Y, Miyazaki J, Suzuki K, Okihara K, Arai Y, Kamba T, Kato M, Nakai Y, Furuse H, Kume H, Ide H, Kitamura H, Yokomizo A, Kimura T, Tomita Y, Ohno K, Kakehi Y.
Int J Clin Oncol 2015 20(5): 1026-34
6 A combination ofDesmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells. Sasaki Hiroshi, Klotz LH, Sugar LM, Venkateswaran V.
Biochem Biophys Res Commun. 2015 Aug 28, 464 (3): 848-54.
7 Results off central pathology review o prostatic Biopsies in a contemporary series from a phaseIII, Multicenter, randomized Controlled trial (SHIP0804). Sasaki H, Kido M, Miki K, Aoki M, Takahashi H, Dokiya T, Yamanaka H, Fukushima M, Egawa S.
Pathol Int. 2015 Apr; 65(4)177-8.
8 Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN. Sugimoto M, Hirama H, Yamaguchi A, Koga H, Hashine K, Ninomiya I, Shinohara N, Maruyama S, Egawa S, Sasaki H, Kakehi Y; The PRIAS-JAPAN study group.
World J Urol 2015, 33(7): 981-7
9 High pressure balloon dilation for vesicourethral anastomotic strictures after radical prostatectomy. Gen Ishii, Takehito Naruoka, Kanako Kasai, Kenichi Hata, Hiroshi Omono, Masayasu Suzuki, Takahiro Kimura and Shin Egawa.
BMC urology 2015, 15, 62
10 Clinical analysis of primary aldosteronism that merged sub clinical Cushing's syndrome. Nozomi Furuta, Takehito Naruoka, Taro Igarashi, Shigehiro Bando, Hiroki Yamada, Takahiro Kimura, Shin Egawa.
It is 185-190 urinary organ 2015 required, 61
11 Organized approach for in-hospital complications "forgotten" pioneer introduction - of hospitalization-related dysfunction prevention system (HPS) using electronic chart in this hospital─ Wataru Tsunoda, Kenjiro Mochio, Ryo Momozaki, Naoki Yamada, Yasuhide Nakayama, Nozomi Furuta, Takahiro Shibata, Osamu Watanabe, Masahiro Anbo.
It is 409-417 security official journal of a scientific society 2015, 10 medical quality
12 Usefulness of low dosage CT for re seninkageketsuishi Takashi Hatano, Hiroyuki Inaba, Katsuhisa Endo, Yoichi Ohira, Munetaka Tomita, Takako Shirakawa, Shin Egawa.
Japanese urolithiasis society magazine 2015, 14(2) :115-117
13 Clinical analysis of T1 high grade bladder cancer. Shunsuke Tuduki, Jun Miki, Jun Moritake, Shoji Kimura, Tatsuya Shimomura, Takahiro Kimura, Koichi Kishimoto, Shin Egawa.
Japanese urinary organ society magazine 2015, 106(2): 71-8.
14 One case of bladder appendix stoma due to appendix cancer. Shoji Kimura, Shinichiro Kira, Haruhisa Koide, Jun Moritake, Yukiko Hiramoto, Masayuki Tomita, Hiroshi Kiyota, Shin Egawa, stone Yamamori, Kazuhiko Yoshida, Akihiko Sakata.
Urology department bulletin 2015, 61(3): 95-8
15 Examination about intravesical recurrence of upper urinary tract epithelial cancer. Shoji Kimura, Jun Miki, Koichi Aikawa, Hideomi Nishikawa, Gen Ishii, Kenichi Hata, Hiroshi Omono, Hiroshi Sasaki, Tatsuya Shimomura, Hiroki Yamada, Takahiro Kimura, Akira Furuta, Kenta Miki, Shin Egawa.
Japanese urology department society magazine 2015, 106 (4): 231-7
16 Influence to give lower urinary tract symptom of laparoscopic prostatic extirpation. Yasutoshi Yoshiyama, Kojiro Tashiro, Shigehiro Bando, Ryuji Tabata, Hiroshi Sasaki, Jun Miki, Kenta Miki, Shin Egawa.
It is 263-9 Japanese Journal of Endourology 2015, 28
17 One case of epididymis malignant lymphoma which showed gentle and quiet growth Fumihiko Urabe, Kojiro Tashiro, Shoji Kimura, Takahiro Kimura, Kenta Miki, Hiroyuki Takahashi, Shin Egawa.
It is 519-23 urination bulletin 2015, 61
1 Outcomes of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: a single institution experience in Japan Hatano T, Chikaraishi K, Inaba H, Katsuhisa Endo K and Egawa S. 
International Journal of Urology 2016, 23(10) 833-8
2 A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer.  Miki K, Sasaki H, Kido M, Takahashi H, Aoki M, Egawa S. 
It is 708-14 BMC cancer 2016, 1, 16
3 Combination therapy withβ3-adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity. Furuta A, Suzuki Y, Kimura S, Koike Y, Egawa S, Yoshimura N.
It is 425-30 Int J Urol 2016, 23
4 Editorial Comment to 5-HT2A receptor enhancement of contractile activity of the porcine urothelium and lamina propria. Furuta A.
Int J Urol 2016, 23:951
5 Time Trends in Histological Features of Latent Prostate Cancer in Japan. Kimura T, Takahashi H, Okayasu M, Kido M, Inaba H, Kuruma H, Yamamoto T, Furusato B, Furusato M, Wada T, Egawa S.
Journal of Urology 2016, May; 195(5): 1415-20
6 Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy. Kobayashi T (Kimura T, Lee C (Department of Urology, Asan Medical Center), Inoue T, Terada N, Kono Y, Kamba T, Kim CS (Department of Urology, Asan Medical Center), Egawa S, Ogawa O.
Japanese Journal of Clinical Oncology 2016, Aug; 46(8): 762-7
7 A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer.  Yoshimura K, Minami T, Nozawa M, Kimura T, Egawa S, Fujimoto H, Yamada A, Itoh K, Uemura H.
European Urology 2016, Jul; 70(1): 35-41
8 Re: Randomized Controlled Trial of Early Zoledronic Acid in Men with Castration-sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance). Kimura T, Egawa S.
European Urology 2016, Apr; 69(4): 754-5
9 Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: A prospective randomized clinical trial. Hata K, Kimura T, Tsuzuki S, Ishii G, Kido M, Yamamoto T, Sasaki H,    Miki J, Yamada H, Furuta A, Miki K, Egawa S.
Int J Urol 2016, 23(11): 923-8
10 Non-immune mediated thrombocytopenia caused by thromboprophylaxis for the perioperative care of urological surgery: A case report and review of the literature. Hata K, Kimura T, Ishii G, Suzuki M, Egawa S.
It is 21-3 International Journal of Surgery Case Reports 2016, 27
11 Do androgen deprivation and the biologically equivalent dose matter in low-dose-rate brachytherapy for intermediate-risk prostate cancer? Tabata R, Kimura T, Kuruma H, Sasaki H, Kido M, Miki K, Takahashi H, Aoki M, Egawa S.
Cancer Med 2016;5(9): 2314-22
12 Meningitis-retention Syndrome; A Case Report Ishii G, Hata K, Aoki S, Suzuki M, Kimura T, Egawa S.
Urology Case Reports 2016, 6, 42-44
13 Skeletal complications in cancer patients with bone metastases. Tsuzuki S, Sun Hee Park, Matthew R Eber, Christopher M Peters, Shiozawa Y.
IJU 2016;23(10): 825-32
14 Infectious disease measures and correspondence - ③ catheter-related urinary tract infection in prostate cancer. Hiroshi Kiyota.
Separate volume drugstore 2016, 67(11): 110-115.
15 Urinary tract infection medical treatment guidelines Hiroshi Kiyota.
Urologic surgery 2016, 29:615-6
16 Medical treatment of kidney AML (angiomyolipoma) associated with tuberous sclerosis. Takashi Hatano.
UrologyToday 2016, 23(4) 196-201 
17 Metabolic syndrome and dysuria, sexual dysfunction Akira Furuta.
Of Chinese medicine burgeon; is 492-534 2016, 58
18 Precaution laparotomy of preoperative planning or laparoscopic surgery is point Radical Prostatectomy, total cystectomy of judgment. Hiroshi Sasaki, Shin Egawa.
Clinic urinary organ 2016, 70 volumes 11 Page844-848
19 One case of adrenocortical carcinoma that combined modality therapy was effective.  Shigehiro Bando, Gen Ishii, Hiroki Yamada, Takahiro Kimura, Nozomi Furuta, Shin Egawa.
It is 15-9 urinary organ 2016;62 required
20 Treatment result of percutaneous cryogenic surgery for narrow path renal tumor. Shigehiro Bando, Jun Miki, Shunsuke Tuduki, Takashi Hatano, Takafumi Yanagisawa, Hayato Shimada, Taro Igarashi, Fumihiko Urabe, Keiji Yasue, Sotaro Kayano, dohonkenkichi, Kanichiro Shimizu, Syunichi Safaoka, Koichi Kishimoto, Shin Egawa.
Japanese Journal of Endourology 2016, 29131-6
21 Upper urinary tract epithelial cancer postoperative clinical analysis. Jun Moritake, Jun Miki, Shunsuke Tuduki, Kenichi Hata, Tatsuya Shimomura, Takahiro Kimura, Akira Furuta, Nozomi Furuta, Shin Egawa.
Japanese urology bulletin 2016, 107(2): 79-86
22 Bladder nephrogenic adenoma in acknowledgment of tendency to reduction Keiichiro Mori, Takahiro Kimura, Hidenori Suzuki, Hirokazu Goto, Shoichi Onodera, Shin Egawa.
Clinical urology department 2016, 70(13): 1045-8
23 An example of prostatic carcinosarcoma. Keiichiro Mori, Takahiro Kimura, Hidenori Suzuki, Hirokazu Goto, Shoichi Onodera, Shin Egawa
Japanese urology department society magazine 2016, 107 volumes 4 266-270
24 One case of primary epididymis adenocarcinoma diagnosed with scrotal edema. Fumihiko Urabe, Takahiro Kimura, Takafumi Yanagisawa, Kojiro Tashiro, Jun Miki, Masaki Nakano, Koichi Kishimoto, Shin Egawa.
Japanese urology department society magazine 2016, 107(3): 193-7.
25 One case using target medicine molecular for kidney Tubulocystic carcinoma with metastasis. Fumihiko Urabe, Jun Miki, Takafumi Yanagisawa, Takahiro Kimura, Masaki Nakano, Masaaki Suzuki, Koichi Kishimoto, Shin Egawa.
Urinary organ 2016 required, 62:569 - 74

▲To the page top